Profectus BioSciences' Series B Round

Profectus BioSciences raised a round of funding on June 05, 2007. Investors include Cross Atlantic Capital Partners.

Profectus Biosciences is a technology based vaccine company devoted to the treatment and prevention of chronic viral diseases. The Company's name, Profectus, when translated from its Latin roots, mean…

Articles about Profectus BioSciences' Series B Round: